The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.
Guidelines on the use of liver biopsy in clinical practice
Open accessAbstract
Erlich is credited with the first liver aspiration in 1883 and subsequently the first percutaneous liver biopsy for diagnostic purposes was reported in 1923.1 The technique has been modified since then, and over the past 50 years it has become a central investigation of hepatic disease. The low mortality (0.01–0.17%) and the relatively low morbidity of this procedure have meant that liver biopsy has become widely used.2 Advances in medical technology and especially in imaging, together with advances in drug therapy have greatly influenced the diagnosis and management of hepatic disease and as a consequence the indications for liver biopsy are changing. In 1991 the British Society of Gastroenterology (BSG), together with the Royal College of Physicians of London, undertook a nationwide audit of percutaneous liver biopsy in 189 health districts.3 It is clear from this audit and from reviewing the literature that there continue to be significant differences in clinical practice with respect to liver biopsy across the United Kingdom, and a lack of standardised protocols between institutions. These guidelines examine the evidence for methods of liver biopsy in adults. ### 2.1 VALIDITY AND GRADING OF RECOMMENDATIONS The guidelines have been produced to conform with the North of England evidence-based guidelines development project.4 5 #### 2.1.1 Categories of evidence The strength of evidence used to formulate these guidelines was graded according to the following system: Ia : Evidence obtained from meta-analysis of randomised controlled trials. Ib : Evidence obtained from at least one randomised controlled trial. IIa : Evidence obtained from at least one well designed controlled study without randomisation. IIb : Evidence obtained from at least one other type of well designed, quasi-experimental study. III : Evidence obtained from well designed, non-experimental descriptive studies such as comparative studies, correlation studies and case studies. IV : Evidence obtained from expert committee reports or opinions or clinical experiences of respected authorities. The evidence category is indicated after the citations in the reference section at the end of these guidelines. #### 2.1.2 Grading of recommendations The strength of each recommendation is dependent on the category of the evidence supporting it, and is graded according to the following system: A : Requires at least one randomised controlled trial as part of the body of literature of overall good quality and consistency addressing the specific recommendation (evidence categories Ia, Ib). B : Requires the availability of clinical studies without randomisation on the topic of recommendation (evidence categories IIa, IIb, III). C : Requires evidence from expert committee reports or opinions or clinical experience of respected authorities, in the absence of directly applicable clinical studies of good quality (evidence category IV). ### 2.2 SCHEDULED REVIEW OF GUIDELINES As methods of diagnosis and tissue sampling change, new evidence will come to light and the content and evidence base for these guidelines should be reviewed frequently. ### 3.1 PERCUTANEOUS LIVER BIOPSY Percutaneous liver biopsy may be classified according to the site of entry of the …
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Natural history of early primary biliary cirrhosis
Metcalf, J. V., Mitchison, H. C., Palmer, J. M., Jones, D. E., Bassendine, M. F., & James, O. F. (1996) · The Lancet · doi:10.1016/s0140-6736(96)04410-8 · Cited by 421
Cited by
Rockey, D. C., Caldwell, S. H., Goodman, Z. D., Nelson, R. C., & Smith, A. D. (2009) · Hepatology · doi:10.1002/hep.22742 · Cited by 1,997
Sasso, M., Beaugrand, M., de Ledinghen, V., Douvin, C., Marcellin, P., Poupon, R., Sandrin, L., & Miette, V. (2010) · Ultrasound in Medicine & Biology · doi:10.1016/j.ultrasmedbio.2010.07.005 · Cited by 862
An Imbalance of Pro- vs Anti-Coagulation Factors in Plasma From Patients With Cirrhosis
Tripodi, A., Primignani, M., Chantarangkul, V., Dell'Era, A., Clerici, M., de Franchis, R., Colombo, M., & Mannucci, P. M. (2009) · Gastroenterology · doi:10.1053/j.gastro.2009.08.045 · Cited by 547
EASL INTERNATIONAL CONSENSUS CONFERENCE ON HEPATITIS B
Jury, T. E. (2003) · Journal of Hepatology · doi:10.1016/s0168-8278(03)00378-7 · Cited by 512
Neuberger, J., Patel, J., Caldwell, H., Davies, S., Hebditch, V., Hollywood, C., Hubscher, S., Karkhanis, S., Lester, W., Roslund, N., et al. (2020) · Gut · doi:10.1136/gutjnl-2020-321299 · Cited by 449
Self-citation
Metadata
- Authors
- Grant, A., & Neuberger, J.
- Venue
- Gut
- Publisher
- BMJ
- Published
- 1999-10-01
- Volume
- 45
- Issue
- suppl 4
- Pages
- IV1-IV11
- ISSN
- 0017-5749 (ISSN-L)
- 1468-3288
- OpenAlex
- W1973375897
- Cited by
- 479
- References
- 1
- FWCI
- 7.66
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Guidelines on the use of liver biopsy in clinical practice. https://app.cochat.ai/papers/10.1136/gut.45.2008.iv1
- The paper
- Grant, A., & Neuberger, J. (1999). Guidelines on the use of liver biopsy in clinical practice. Gut. https://doi.org/10.1136/gut.45.2008.iv1
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.